Clostridium Chauvoei + Clostridium Novyi + Clostridium Perfringens Type C Bacterin Toxoid + Clostridium Perfringens Type D Bacterin Toxoid + Clostridium Septicum + Clostridium Sordellii
13 adverse event reports submitted to the FDA
Important: Adverse event reports do not establish that a drug caused or contributed to the event. Consult your veterinarian before making treatment decisions.
13
Total Reports
12
Deaths Reported
9230.0%
Death Rate
Active Ingredients
Clostridium ChauvoeiClostridium NovyiClostridium Perfringens Type C Bacterin ToxoidClostridium Perfringens Type D Bacterin ToxoidClostridium SepticumClostridium Sordellii
Administration Routes
SubcutaneousUnknown
Species Affected
Cattle 12
Bison 1
Most Affected Breeds
Cattle (other) 7
Aberdeen Angus 3
American bison 1
Crossbred Bovine/Cattle 1
Cattle (unknown) 1
Most Reported Reactions
Death 12
Lack of efficacy - NOS 4
Lack of efficacy (bacteria) - NOS 4
Respiratory signs 2
Lack of efficacy (virus) - NOS 2
Unclassifiable adverse event 2
NT - Abnormal necropsy finding NOS 2
INEFFECTIVE, ANTIBIOTIC 1
Neurological signs NOS 1
Myopathy 1
Haemothorax 1
Other abnormal test result NOS 1
Outcome Breakdown
Died
12 (54.5%)
Outcome Unknown
4 (18.2%)
Recovered/Normal
3 (13.6%)
Ongoing
2 (9.1%)
Euthanized
1 (4.5%)
Source: FDA Center for Veterinary Medicine — Adverse Event Reports. Data reflects voluntary submissions and may not represent actual incidence rates.